Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Automera aims to leverage its unique understanding of autophagy, drug development capabilities, and access to quantum chemistry and generative AI-enabled insights to enhance its drug development programs. Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program. The company was founded by co-founders Associate Professor Michael Lazarou, Loong Wang, and Taiyang Zhang at Talo Labs Pte Ltd.
Company Details
- Employees
- 11
- Founded
- 2022
- Address
- 79 Science Park Drive #04-05, Cintech Iv,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://automeratx.com
- HQ
- Singapore
Automera Questions
Automera's website is https://automeratx.com
Automera's LinkedIn profile is https://www.linkedin.com/company/automeratx
Automera has
11 employees.
View email and phone details for 11
employees at Automera.
Automera's industry is
Biotechnology Research
Automera's top competitors are
Talo Labs,
Paratus Sciences,
Hummingbird Bioscience,
Kayothera,
Engine Biosciences,
Ren,
Nanodigmbio Biotechnology,
Rush,
Accelerator Life Science Partners,
Qdx.
Automera's categories are Biotechnology Research
Automera's founding year is 2022
